Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) : Updated statement of the Austrian Society of Pneumology (ASP)만성 폐 질환 환자에 초점을 맞춘 SARS-CoV-2 감염 환자 관리(2022년 1월 10일 기준) : 오스트리아 폐렴 학회(ASP)의 업데이트된 성명Article Published on 2022-05-012022-09-11 Journal: Wiener Klinische Wochenschrift [Category] Coronavirus, COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition addressed Adults affected ASP association breakdown bronchoscopy Care cause children chronic chronic lung disease chronic lung diseases concerning coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease delta variant died disease effective elevated expected Health health system Immune modulators increased risk Infection lockdown Long Long COVID lung Lung disease Lung function measure Mechanical mechanical ventilation Most patients Omicron variant Patient patients patients with SARS-CoV-2 Pediatric lung disease. Pneumology predominant Prevent professional provided reaction rising risk risk of death SARS-CoV-2 SARS-CoV‑2 SARS-CoV‑2 infection severe acute respiratory syndrome Coronavirus severe COVID-19 disease social distancing Society Spread therapy vaccination vaccination rate Vaccinations variant [DOI] 10.1007/s00508-022-02018-x PMC 바로가기 [Article Type] Article
One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis낭포성 섬유증 환자의 독일 집단에서 SARS-CoV-2 유병률의 1년 모니터링Article Published on 2022-03-242022-09-12 Journal: BMC Pulmonary Medicine [Category] MERS, SARS, 진단, [키워드] anti-SARS-CoV-2 IgG antibody anticipated Clinical course Clinical data clinical impact Clinical outcome cohort of patient collected coronavirus disease cough COVID-19 described fatigue fibrosis Germany headache higher risk Hospitalized impair individual infected patient Infection Lung function molecular Nasopharyngeal swab observation pandemic Patient positive Prevalence recorded Registered Saliva SARS-CoV-2 SARS-COV-2 infection screened serology severe COVID-19 Symptom tested the SARS-CoV-2 [DOI] 10.1186/s12890-022-01900-8 PMC 바로가기 [Article Type] Article
1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia – A prospective observational studyObservational Study Published on 2022-03-032022-10-04 Journal: NPJ Primary Care Respiratory Medicine [Category] MERS, SARS, 임상, [키워드] 6MWT abnormality affected alteration components concerning COVID-19 CT scan Follow-up form functional hospital impairment lowest lung Lung function lung lobes Mental morbidity and mortality outcome Patient patients with SARS-CoV-2 persistence physical Pneumonia Prognosis prospective observational study Quality of life questionnaire radiological recruited reduction reported respiratory SARS-CoV-2 SARS-CoV-2 pneumonia significantly SpO2 submitted survivor Switzerland Symptoms symptoms onset the patient [DOI] 10.1038/s41533-022-00273-z PMC 바로가기 [Article Type] Observational Study
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19COVID-19 관리를 위한 가용성 에폭사이드 가수분해효소 억제제에 의한 내인성 해결 경로 활성화Review Published on 2022-03-012022-09-11 Journal: Archiv der Pharmazie [Category] SARS, 비임상, 임상, 치료제, [키워드] activate administration Anti-inflammatory approach breath COVID-19 COVID-19 patients Cytokine storm disease models EET epoxide fatty Fatty acid fatty acids immune immune response IMPROVE increase inhibitor inhibitors Lung disease Lung diseases Lung function Lung inflammation management mechanism mechanisms Mitigation organ organ damage outcome pathway Polyunsaturated proresolving mediators PROTECT reduce resource Severe case severe cases soluble epoxide hydrolase inhibitors. the cytokine storm Treatment [DOI] 10.1002/ardp.202100367 PMC 바로가기 [Article Type] Review
Prognosis and antibody profiles in survivors of critical illness from COVID-19: a prospective multicentre cohort studyCOVID-19로 인한 중병 생존자의 예후 및 항체 프로필: 전향적 다기관 코호트 연구Multicenter Study Published on 2022-03-012022-09-11 Journal: British journal of anaesthesia [Category] MERS, SARS, 진단, 치료기술, [키워드] antibody Antigen carbon monoxide Characteristics Chest computed tomography China clinical Coagulation cognitive Cognitive function cohort study Computed tomography Control COVID-19 Critical Critical illness declined detectable diffusing diffusing capacity enrolled Ex vivo Follow-up function hospital IgG Immune cell immune cells Immune status Immunity Immunoglobulin impairment infected with COVID-19 inter-quartile range kidney life liver lung Lung function lung volumes lymphocyte Lymphocyte count majority mechanical ventilation Mental multicentre Multiple Neutralising Antibodies neutralising antibody Other outcome parameter participated Patient peptide physical predicted profile prospective cohort study remained required Residual volume SARS-CoV-2 significantly subtype survivor Survivors titre titres Trial Volume were assessed [DOI] 10.1016/j.bja.2021.11.024 PMC 바로가기 [Article Type] Multicenter Study
Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease심한 covid-19 질병으로부터 회복되는 개인에서 혈청 cdcp1의 높은 수준Research Paper Published on 2022-02-282022-09-10 Journal: Aging (Albany NY) [Category] MERS, 바이오마커, [키워드] Biomarker Biomarkers carbon monoxide CDCP1 correlation correlations COVID-19 difference diffusing diffusing capacity discharge group hospital hospital discharge Hospitalization identify implication independent predictors Indicator individual Inflammatory biomarker inflammatory biomarkers laboratory-confirmed Laboratory-confirmed COVID-19 Level lung abnormalities lung abnormality Lung function median onset of symptom Patient predictor prognostic recovery recruited SARS-CoV-2-infected patient SARS-CoV-2-infected patients serum Severe case severe cases severe COVID-19 disease severe disease severity severity of COVID-19 significant difference significantly lower Spain sputum Sputum sample sputum samples survivor Symptom were measured [DOI] 10.18632/aging.203898 PMC 바로가기 [Article Type] Research Paper
The Impact of Ambient Environmental and Occupational Pollution on Respiratory DiseasesReview Published on 2022-02-272022-10-29 Journal: International Journal of Environmental Research an [Category] Coronavirus, [키워드] ambient ambient pollution asbestos Asthma attack cause caused children chronic obstructive communicable disease COVID-19 death disease exacerbate Impact lung lung cancer Lung disease Lung function occupational occupational pollution pneumoconiosis Pollution preventive intervention produced pulmonary disease reduce respiratory Respiratory disease respiratory diseases risk risk factor severe coronavirus disease suggested while [DOI] 10.3390/ijerph19052788 PMC 바로가기 [Article Type] Review
Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge병원 배출 6 개월 후 폐 확산 능력 감소 된 Covid-19 생존자에서 상피 및 내피 세포 마커의 혈장 수준 증가Observational Study Published on 2022-02-212022-09-01 Journal: Respiratory Research [Category] MERS, 바이오마커, 임상, 진단, [키워드] abnormality acute disease acute respiratory distress acute respiratory distress syndrome Adhesion Molecule angiopoietin ARDS carbon monoxide Cell Characteristics circulating clinical Clinical characteristics COVID-19 diffusing diffusing capacity discharge disease DLCO Dyspnoea E-selectin elevated endothelial Endothelial cell endothelial marker Endothelial markers epithelial Epithelial markers Follow-up hospital discharge Hospitalization hypertension independent risk factor independent risk factors individuals intercellular intercellular adhesion molecule leukocyte Level lung lung damage Lung function marker multivariate regression analysis observational study Occurrence Older Organizing pneumonia pathophysiology Patient patients plasma Plasma levels Pneumonia Post-COVID Prospective Protease inhibitor Protein Pulmonary embolism pulmonary embolisms reduced respiratory distress Result risk factor Risk factors selectin Sequelae severe COVID-19 severity Severity Score SLPI Smokers spirometry suffered supplementary material survivor Survivors syndrome [DOI] 10.1186/s12931-022-01955-5 PMC 바로가기 [Article Type] Observational Study
Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trialClinical Trial Published on 2022-02-082022-10-04 Journal: eLife [Category] COVID19(2023년), MERS, SARS, 임상, [키워드] abnormality acute COVID-19 Antibody titer assist characterized classification clinical clinical feature Clustering collected Computed tomography conducted COVID-19 CRP level demonstrated Follow-up follow-up visits Frequency functional Health hospitalized COVID-19 patient Human ICU identify IL-6 Incomplete initiated intensive care investigated laboratory parameter Logistic regression Long COVID lung Lung CT Lung function machine learning machine learning classifier management Mild MONITOR multicenter observational study Multicenter trial parameters participant phenotype Post-COVID-19 syndrome Prevalence Prevent pulmonary pulmonary recovery radiological ranged recruited reported risk risk factor severity state Survivors Symptom Symptoms systemic inflammation treat Trial [DOI] 10.7554/eLife.72500 PMC 바로가기 [Article Type] Clinical Trial
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary EmbolismMolecular Biosciences Published on 2022-02-032022-10-31 Journal: Frontiers in Molecular Biosciences [Category] COVID-19, [키워드] 6MWT abnormality addition adult COVID-19 patient carried chronic lung disease clinical history complication of COVID-19 Computed tomography conducted COVID - 19 COVID-19 COVID-19 patient demonstrated Diagnosis diffusion capacity DLCO Dyspnoea Embolism evaluated Exercise capacity feature Follow-up functional consequence High-resolution HRCT impairment KCO lung Lung function mMRC Month Patient Pneumonia predicted previous study pulmonary pulmonary angiography Pulmonary embolism Pulmonary function Pulmonary function test Respiratory function retrospective significant difference significantly lower six minute walk test spirometry subject the patient those without PE were excluded [DOI] 10.3389/fmolb.2021.809186 PMC 바로가기 [Article Type] Molecular Biosciences